108 related articles for article (PubMed ID: 24789023)
1. Is extended-release guaifenesin no better than a placebo?
O'Connell OJ
Respir Care; 2014 May; 59(5):788-9. PubMed ID: 24789023
[No Abstract] [Full Text] [Related]
2. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
[TBL] [Abstract][Full Text] [Related]
3. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
4. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.
Rubin BK
Chest; 1999 Jul; 116(1):195-200. PubMed ID: 10424525
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
LaForce C; Gentile DA; Skoner DP
Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms.
Albrecht H; Vernon M; Solomon G
Respir Res; 2012 Dec; 13(1):118. PubMed ID: 23270519
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice].
Ovchinnikov AI; Paniakina MA; Korostelev SA; Mitiuk AM
Vestn Otorinolaringol; 2014; (2):86-9. PubMed ID: 24781181
[TBL] [Abstract][Full Text] [Related]
8. [Round table. Relevant controls and usefulness of treatments modifying bronchial secretions (author's transl)].
Bull Physiopathol Respir (Nancy); 1973; 9(2):417-71. PubMed ID: 4778961
[No Abstract] [Full Text] [Related]
9. Alterations of nasal mucociliary clearance in association with HIV infection and the effect of guaifenesin therapy.
Rosen EJ; Calhoun KH
Laryngoscope; 2005 Jan; 115(1):27-30. PubMed ID: 15630360
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections.
Kikano G
Postgrad Med; 2009 May; 121(3):173-5. PubMed ID: 19491556
[TBL] [Abstract][Full Text] [Related]
11. Bronchopulmonary effects of paraquat and expectorants.
Cambar PJ; Aviado DM
Arch Environ Health; 1970 Apr; 20(4):488-94. PubMed ID: 5429990
[No Abstract] [Full Text] [Related]
12. A review of studies on the pharmacology of the expectorants and inhalants.
Boyd EM
Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):55-60. PubMed ID: 5440315
[No Abstract] [Full Text] [Related]
13. Question: does guaifenesin improve outcomes in patients with cough associated with upper respiratory infection compared with no intervention?
Ramirez N; Jared M; Hodgden J; Toalson W
J Okla State Med Assoc; 2012 Oct; 105(10):397-8. PubMed ID: 23316675
[No Abstract] [Full Text] [Related]
14. Guaifenesin in rhinitis.
Storms W; Farrar JR
Curr Allergy Asthma Rep; 2009 Mar; 9(2):101-6. PubMed ID: 19210898
[TBL] [Abstract][Full Text] [Related]
15. [Effects of various expectorants on sputum viscoelasticity in vivo (author's transl)].
Shimura S; Sato S; Aoki T; Takishima T
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Mar; 18(3):161-70. PubMed ID: 7392320
[No Abstract] [Full Text] [Related]
16. [General practice-field trials of Linctifed with 17871 patients with inflammatory diseases of the respiratory tract].
Neumeyer G
Med Welt; 1979 Sep; 30(37):1374-7. PubMed ID: 41152
[No Abstract] [Full Text] [Related]
17. [Sobrerol as expectorant in patients with stable chronic respiratory tract infections. A controlled study].
Shang H; Grosgurin P; Medici TC
Schweiz Med Wochenschr; 1982 Dec; 112(50):1846-8. PubMed ID: 6760390
[TBL] [Abstract][Full Text] [Related]
18. Letter: Expectorant effect of glyceryl guiacolate.
Chodosh S; Medici TC
Chest; 1973 Oct; 64(4):543-5. PubMed ID: 4743966
[No Abstract] [Full Text] [Related]
19. Changes in the fibre system and viscosity of the sputum of bronchitis during treatment with bromhexine and guaiphenesin (guaiacol glyceryl ether).
Bürgi H
Scand J Respir Dis Suppl; 1974; 90():81-5. PubMed ID: 4618378
[No Abstract] [Full Text] [Related]
20. Sputum liquefiers.
Palmer KN
Br J Dis Chest; 1966 Oct; 60(4):177-81. PubMed ID: 5969934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
